IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Octagon Capital Advisors LP

Q4 2020 Holdings

Filed 2021-02-16 | 31 holdings | $59.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$18.2M1,041,39830.5%
Arvinas Inc(ARVN)COM04335A105$15.2M178,50025.3%
Cardiff Oncology Inc(CRDF)COM14147L108$11.7M650,00019.5%
Arcus Biosciences Inc(RCUS)COM03969F109$7.8M300,00013.0%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$2.8M100,0004.7%
Aclaris Therapeutics Inc(ACRS)COM00461U105$2.3M350,0003.8%
Axsome Therapeutics Inc(AXSM)COM05464T104$1.6M20,0002.7%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$31.4K548,3740.1%
I MAB(NBP)SPONSORED ADS44975P103$21.4K454,5500.0%
Curis Inc(CRISEUR)COM NEW231269200$18.0K2,200,0000.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$15.7K377,7770.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$15.4K250,0000.0%
Gossamer BIO Inc(GOSS)COM38341P102$15.1K1,563,1380.0%
Acceleron Pharma Inc(XLRN)COM00434H108$14.4K112,3630.0%
Chemocentryx Inc(CCXIEUR)COM16383L106$13.9K225,0760.0%
Avidity Biosciences Inc(RNA)COM05370A108$11.0K430,0410.0%
Dyne Therapeutics Inc(DYN)COM26818M108$10.1K481,5380.0%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$8.5K320,4400.0%
Calliditas Therapeutics ABSPONSERED ADS13124Q106$6.7K200,0000.0%
Fibrogen Inc(FGENEUR)COM31572Q808$5.4K146,0140.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$5.2K295,2380.0%
Revolution Medicines Inc(RVMD)COM76155X100$5.0K126,1360.0%
Kura Oncology Inc(KURA)COM50127T109$4.9K150,0000.0%
Iveric BIO Inc(OPHTEUR)COM46583P102$4.7K680,0360.0%
Helix Acquisition CorpCOM CL AG4444C102$4.5K400,0000.0%
Kronos BIO Inc(KRON1USD)COM50107A104$4.4K146,1730.0%
Jiya Acquisition CorpCOM CL A47760M102$3.1K300,0000.0%
Viela BIO Inc(VIE)COM926613100$3.1K85,4090.0%
Inventiva SA(IVA)ADS46124U107$2.9K200,0000.0%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$2.3K75,2270.0%
Kadmon Hldgs Inc(KDMN)COM48283N106$1.8K434,1140.0%